Verastem to Present New Data at the 12th International Mesothelioma Interest Group Conference

Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it will present new data at the 12th International Mesothelioma Interest Group Conference being held October 22-24, 2014, in Cape Town, South Africa. "The Cancer Stem Cell Inhibitors VS-6063 and VS-5584 Exhibit Synergistic Anticancer Activity in Preclinical Models of Mesothelioma" Investigators and members of the Verastem leadership team will give oral presentations discussing the Company's development programs targeting cancer stem cells with a focus on lead inhibitor VS-6063 .

http://ift.tt/1scFWuA